Literature DB >> 29052812

Fumarase Deficiency: A Safe and Potentially Disease Modifying Effect of High Fat/Low Carbohydrate Diet.

B Ryder1, F Moore2, A Mitchell3, S Thompson1,3, J Christodoulou1,4,5,6,7, S Balasubramaniam8,9,10.   

Abstract

Fumarate hydratase deficiency (FHD) caused by biallelic alterations of the FH (fumarate hydratase) gene is a rare disorder of the tricarboxylic acid cycle, classically characterized by encephalopathy, profound psychomotor retardation, seizures, a spectrum of brain abnormalities and early death in childhood. Less common milder phenotypes with moderate cognitive impairment and long-term survival have been reported. In addition, heterozygous mutations of the FH gene are responsible for hereditary leiomyomatosis and renal cell cancer (HLRCC). There is currently no recommended disease modifying treatment for FHD and only isolated reports of unsuccessful dietary modifications. Herein, we describe the safe and possibly disease modifying effect of a high fat, low carbohydrate diet in a 14-year-old female with severe FHD.

Entities:  

Keywords:  Disease modifying; Fumarase deficiency; High fat diet

Year:  2017        PMID: 29052812      PMCID: PMC6122040          DOI: 10.1007/8904_2017_65

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  20 in total

1.  Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations.

Authors:  M Maradin; K Fumić; H Hansikova; M Tesarova; L Wenchich; S Dorner; V Sarnavka; J Zeman; I Barić
Journal:  J Inherit Metab Dis       Date:  2006-08-05       Impact factor: 4.982

2.  Detection of a novel FH whole gene deletion in the propositus leading to subsequent prenatal diagnosis in a sibship with fumarase deficiency.

Authors:  Amelia R Mroch; Mark Laudenschlager; Jason D Flanagan
Journal:  Am J Med Genet A       Date:  2011-11-08       Impact factor: 2.802

3.  Fumarate hydratase deficiency in monozygotic twins.

Authors:  Tonya M Phillips; James B Gibson; Dale A Ellison
Journal:  Pediatr Neurol       Date:  2006-08       Impact factor: 3.372

Review 4.  Fumaric aciduria: an overview and the first Brazilian case report.

Authors:  Gabriella Allegri; Marcia J Fernandes; Fernanda B Scalco; Patricia Correia; Ruth E Simoni; Juan C Llerena; Maria L Costa de Oliveira
Journal:  J Inherit Metab Dis       Date:  2010-06-15       Impact factor: 4.982

5.  A rare cause of opistotonus; fumaric aciduria: The first case presentation in Turkey.

Authors:  Osman Baştuğ; Fatih Kardaş; Mehmet Adnan Öztürk; Hülya Halis; Şeyma Memur; Levent Korkmaz; Zuhal Tağ; Tamer Güneş
Journal:  Turk Pediatri Ars       Date:  2014-03-01

6.  Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.

Authors:  Fatih Ezgu; Pavel Krejci; Wiliam R Wilcox
Journal:  Gene       Date:  2013-04-20       Impact factor: 3.688

7.  Molecular and biochemical investigations in fumarase deficiency.

Authors:  M Deschauer; Z Gizatullina; A Schulze; M Pritsch; C Knöppel; M Knape; S Zierz; F N Gellerich
Journal:  Mol Genet Metab       Date:  2006-02-28       Impact factor: 4.797

8.  Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics.

Authors:  Heli J Lehtonen
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.446

9.  A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle.

Authors:  Anthony C Smith; Alan J Robinson
Journal:  BMC Syst Biol       Date:  2011-06-29

Review 10.  HIF and fumarate hydratase in renal cancer.

Authors:  S Sudarshan; W M Linehan; L Neckers
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

View more
  2 in total

Review 1.  Fumarate hydratase in cancer: A multifaceted tumour suppressor.

Authors:  Christina Schmidt; Marco Sciacovelli; Christian Frezza
Journal:  Semin Cell Dev Biol       Date:  2019-05-22       Impact factor: 7.727

Review 2.  The impact of mitochondria on cancer treatment resistance.

Authors:  Michelle van der Merwe; Gustav van Niekerk; Carla Fourie; Manisha du Plessis; Anna-Mart Engelbrecht
Journal:  Cell Oncol (Dordr)       Date:  2021-07-09       Impact factor: 6.730

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.